The American Journal of Managed Care

The American Journal of Managed Care The American Journal of Managed Care is a peer-reviewed, indexed publication. It has the #1 Impact Factor in the MC market.

Its accompanying website, AJMC.com, offers the latest news in health policy, disease states, and managed care. The American Journal of Managed Care is a peer-reviewed, indexed publication reaching over 48,500 MC executives.

Great conversations don’t always end when the sessions do.We’re closing out Day 1 of PCOC with a little Nashville spirit...
09/24/2026

Great conversations don’t always end when the sessions do.

We’re closing out Day 1 of PCOC with a little Nashville spirit and an opportunity for attendees, faculty, and colleagues to connect beyond the agenda.

Thank you to everyone who joined us for a full day of insights and discussion. We’ll see you tomorrow for Day 2.

09/24/2026

Day 1 of Patient-Centered Oncology Care® is well underway in Nashville!

We’re off to a great start with insightful discussions, meaningful connections, and important conversations around the evolving oncology care landscape.

It’s been a pleasure learning and connecting with everyone joining us today, and there’s still plenty more to come. We hope you’re enjoying as much as we are!

In an interview at the National Association of Specialty Pharmacy (NASP) inSPire2026 conference, Geeta Nayyar, MD, MBA, ...
09/24/2026

In an interview at the National Association of Specialty Pharmacy (NASP) inSPire2026 conference, Geeta Nayyar, MD, MBA, says 's real health care payoff is cutting administrative friction with clean data and clinical leadership.

Read the Q&A: https://hubs.li/Q04ycPJp0

The   kicks off tomorrow!In a recent interview, Stephen "Fred" Divers, MD, previewed the meeting, including his session ...
09/23/2026

The kicks off tomorrow!

In a recent interview, Stephen "Fred" Divers, MD, previewed the meeting, including his session on the Oncology Care Index and the gap in adoption in oncology.

Watch here: https://hubs.li/Q04y9L4Q0

𝐖𝐡𝐚𝐭 𝐝𝐨𝐞𝐬 𝐅𝐀𝐂𝐓 𝐚𝐜𝐜𝐫𝐞𝐝𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐚𝐜𝐭𝐮𝐚𝐥𝐥𝐲 𝐫𝐞𝐪𝐮𝐢𝐫𝐞, 𝐚𝐧𝐝 𝐢𝐬 𝐢𝐭 𝐧𝐞𝐜𝐞𝐬𝐬𝐚𝐫𝐲 𝐟𝐨𝐫 𝐬𝐚𝐟𝐞 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐨𝐟 𝐂𝐀𝐑 𝐓-𝐜𝐞𝐥𝐥 𝐭𝐡𝐞𝐫𝐚𝐩𝐲?Tara Graff, D...
09/21/2026

𝐖𝐡𝐚𝐭 𝐝𝐨𝐞𝐬 𝐅𝐀𝐂𝐓 𝐚𝐜𝐜𝐫𝐞𝐝𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐚𝐜𝐭𝐮𝐚𝐥𝐥𝐲 𝐫𝐞𝐪𝐮𝐢𝐫𝐞, 𝐚𝐧𝐝 𝐢𝐬 𝐢𝐭 𝐧𝐞𝐜𝐞𝐬𝐬𝐚𝐫𝐲 𝐟𝐨𝐫 𝐬𝐚𝐟𝐞 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐨𝐟 𝐂𝐀𝐑 𝐓-𝐜𝐞𝐥𝐥 𝐭𝐡𝐞𝐫𝐚𝐩𝐲?

Tara Graff, DO, MS, walks through the operational reality: documentation from apheresis through years of follow-up, staff training, histology confirmation, and a program director who knows every step.

Debra Patt, MD, PhD, MBA, brings real-world data on patients treated at nonaccredited sites. She argues that accreditation should support quality without blocking access—pointing to payers as the sticking point when coverage denials rest on accreditation status alone.

Plus, learn how Texas Oncology built its bispecific step-up dosing infrastructure first — including remote monitoring with a 3.5-minute average nurse response time — as a stepping stone to CAR T-cell therapy delivery. 🎥

Working-age adults with private   are paying off medical  , often draining savings, delaying care, or cutting back on ne...
09/20/2026

Working-age adults with private are paying off medical , often draining savings, delaying care, or cutting back on necessities as a result.

Learn more here: https://hubs.li/Q04xVKcf0

Jeff Hunnicutt emphasized vetting   vendors, scaling beyond single-use cases, and  's potential to streamline workflows ...
09/19/2026

Jeff Hunnicutt emphasized vetting vendors, scaling beyond single-use cases, and 's potential to streamline workflows in an interview at the Community Oncology Alliance Payer Exchange & Innovation Summit.

Watch here: https://hubs.li/Q04xVJZr0

In an interview at the Community Oncology Alliance Payer Exchange & Innovation Summit, Debra Patt, MD, PhD, MBA, MPH, di...
09/18/2026

In an interview at the Community Oncology Alliance Payer Exchange & Innovation Summit, Debra Patt, MD, PhD, MBA, MPH, discussed adoption, administrative burden, and strategies to streamline prior authorization in oncology.

Read the Q&A here: https://hubs.li/Q04xVJyN0

𝐇𝐨𝐰 𝐝𝐨 𝐩𝐚𝐲𝐞𝐫𝐬 𝐜𝐨𝐦𝐩𝐚𝐫𝐞 𝟐 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬 𝐭𝐡𝐚𝐭 𝐰𝐞𝐫𝐞 𝐧𝐞𝐯𝐞𝐫 𝐬𝐭𝐮𝐝𝐢𝐞𝐝 𝐬𝐢𝐝𝐞 𝐛𝐲 𝐬𝐢𝐝𝐞?In this video, experts dig into the challenge of...
09/18/2026

𝐇𝐨𝐰 𝐝𝐨 𝐩𝐚𝐲𝐞𝐫𝐬 𝐜𝐨𝐦𝐩𝐚𝐫𝐞 𝟐 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬 𝐭𝐡𝐚𝐭 𝐰𝐞𝐫𝐞 𝐧𝐞𝐯𝐞𝐫 𝐬𝐭𝐮𝐝𝐢𝐞𝐝 𝐬𝐢𝐝𝐞 𝐛𝐲 𝐬𝐢𝐝𝐞?

In this video, experts dig into the challenge of reading vitiligo trial data across separate studies—why matching timepoints matters, what the 1-year numbers show, and how factors like member churn and FDA labeling shape real-world coverage decisions.

𝐖𝐚𝐭𝐜𝐡 𝐍𝐨𝐰: https://hubs.li/Q04xHFN90

Building a cellular therapy program takes a multidisciplinary team.Meet the Tennessee Oncology leaders sharing their per...
09/17/2026

Building a cellular therapy program takes a multidisciplinary team.

Meet the Tennessee Oncology leaders sharing their perspectives on September 30:
💡 Michael T. Byrne, DO, FACP
💡 Rhiannon N. Dorris, PharmD, BCOP, BCPS
💡 Amanda Lachapelle, BSN, RN, TCTCN
💡 Martie Steinfeld
💡 Xiaoxiao Zhang, MBA, MSN, AG-ACNP

Hear lessons learned from across clinical, operational, pharmacy, and administrative roles as the faculty explores what it takes to develop a cellular therapy program in the community oncology setting.

Register for the free webinar: https://hubs.ly/Q04xNPXN0

Address

Plainsboro, NJ

Alerts

Be the first to know and let us send you an email when The American Journal of Managed Care posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to The American Journal of Managed Care:

Shortcuts

Share